[Profile of garenoxacin as respiratory quinolones (discussion)].
Yamaguchi
Kezo
K
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects; D002986:Clinical Trials as Topic; D024881:Drug Resistance, Bacterial; D024841:Fluoroquinolones / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D006801:Humans; D010349:Patient Compliance; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000382:microbiology; D014018:Tissue Distribution
D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones; C419689:garenoxacin